# Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

> **NCT06760650** · NA · NOT_YET_RECRUITING · sponsor: **Saint-Joseph University** · enrollment: 35 (estimated)

## Conditions studied

- Chronic Kidney Disease Stage 4
- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease Stage 5
- Diabetes Mellitus
- Fluorescein Angiography
- Acute Kidney Injury

## Interventions

- **DIAGNOSTIC_TEST:** Fluorescein angiography

## Key facts

- **NCT ID:** NCT06760650
- **Lead sponsor:** Saint-Joseph University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06760650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06760650, "Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06760650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
